The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists.
A novel series of [2.2.1]-azahydantoins has been designed and synthesized in an enantiospecific manner. The ability of these compounds to act as antagonists to the androgen receptor was investigated and several were found to have potent activity in vitro.